Matthias F. Melzig
- Biochemistry top 0.5%
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds 11
-
- Herbal Medicine Research Studies 11
- Biotechnology top 1%
- Immunology top 2%
- Toxin Mechanisms and Immunotoxins 48
-
- Natural product bioactivities and synthesis 52
-
- Phytochemistry and Biological Activities 24
-
- Natural Antidiabetic Agents Studies 15
-
- Essential Oils and Antimicrobial Activity 13
-
- Phytochemistry and Bioactive Compounds 10
- Co-authors
- Tina BuchholzAlexander WengEric WoithStefan BöttgerHendrik FuchsWenyan XieGregor FuhrmannAnna K. Kiss
- Partner nations
- GermanyPolandUnited States
In The Last Decade
Matthias F. Melzig
229 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 142
- Biochemistry 772
- Pharmacology 586
- Complementary and alternative medicine 497
- Biotechnology 491
- Immunology 957
Countries citing papers authored by Matthias F. Melzig
This map shows the geographic impact of Matthias F. Melzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias F. Melzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias F. Melzig more than expected).
Fields of papers citing papers by Matthias F. Melzig
This network shows the impact of papers produced by Matthias F. Melzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias F. Melzig. The network helps show where Matthias F. Melzig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias F. Melzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 18 | |
| 4 | 2020 | 20 | |
| 5 | 2018 | 89 | |
| 6 | 2018 | 53 | |
| 7 | 2014 | 62 | |
| 8 | 2012 | 39 | |
| 9 | 2010 | 7 | |
| 10 | 2010 | 56 | |
| 11 | 2008 | 1 | |
| 12 | 2008 | 14 | |
| 13 | 2007 | 19 | |
| 14 | Screening of selected Arabian medicinal plant extracts for inhibitory activity against peptidases. | 2006 | 11 |
| 15 | 2003 | 22 | |
| 16 | 2003 | 35 | |
| 17 | Cytotoxic constituents from Exostema mexicanum and Artemisia afra, two traditionally used plant remedies. | 2002 | 5 |
| 18 | 2000 | 40 | |
| 19 | 1998 | 17 | |
| 20 | 1991 | 2 |
About Matthias F. Melzig
Matthias F. Melzig is a scholar working on Complementary and alternative medicine, Biotechnology and Pharmacology, having authored 247 papers that have together received 6.2k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (52 papers), Toxin Mechanisms and Immunotoxins (48 papers), Phytochemistry and Biological Activities (24 papers), Natural Antidiabetic Agents Studies (15 papers), Essential Oils and Antimicrobial Activity (13 papers), Herbal Medicine Research Studies (11 papers), Pharmacological Effects of Natural Compounds (11 papers) and Phytochemistry and Bioactive Compounds (10 papers). The work is most often cited by research in Biochemistry (772 citations), Pharmacology (586 citations) and Complementary and alternative medicine (497 citations). Matthias F. Melzig has collaborated with scholars based in Germany, Poland and United States. Frequent co-authors include Tina Buchholz, Alexander Weng, Eric Woith, Stefan Böttger, Hendrik Fuchs, Wenyan Xie, Gregor Fuhrmann, Anna K. Kiss, Monika E. Czerwińska and Christopher Bachran.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.